ClearPoint Neuro, Inc. Common Stock (CLPT) Stock Price

CLPTStock

$9.07−64.12%52W

Market Cap$276.67M

P/E—

PEG Ratio0.61

Div yield—

Beta1.33

CLPT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-22.53%

Price vs S&P 500 (4W)-33.75%

PEG Ratio0.61

VGM Score39.72

Book Value / Share (Quarterly)$0.35

P/TBV (Annual)28.87x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)21.62%

Cash Flow / Share (Quarterly)$-1.03

Price vs S&P 500 (YTD)-45.63%

Gross Margin (TTM)62.61%

Net Profit Margin (TTM)-81.76%

EPS (TTM)$-1.18

10-Day Avg Trading Volume0.72M

EPS Excl Extra (TTM)$-1.18

Revenue Growth (5Y)23.57%

EPS (Annual)$-0.90

ROI (Annual)-33.13%

Gross Margin (Annual)61.38%

Net Profit Margin (5Y Avg)-77.99%

Cash / Share (Quarterly)$0.96

Revenue Growth QoQ (YoY)18.07%

ROA (Last FY)-26.13%

Revenue Growth TTM (YoY)25.86%

EBITD / Share (TTM)$-1.04

ROE (5Y Avg)-68.81%

Operating Margin (TTM)-73.42%

Cash Flow / Share (Annual)$-0.83

P/B Ratio25.68x

P/B Ratio (Quarterly)49.65x

Net Income / Employee (Annual)$-148,500

EV / Revenue (TTM)7.04x

Net Interest Coverage (TTM)-20.69x

ROA (TTM)-40.87%

EPS Incl Extra (Annual)$-0.90

Current Ratio (Annual)5.91x

Quick Ratio (Quarterly)3.75x

3-Month Avg Trading Volume0.73M

52-Week Price Return-64.12%

Revenue / Employee (TTM)$245,800

Tangible BV / Share (Quarterly)$0.18

P/S Ratio (Annual)7.48x

Asset Turnover (Annual)0.38x

52-Week High$28.10

Operating Margin (5Y Avg)-76.68%

EPS Excl Extra (Annual)$-0.90

CapEx CAGR (5Y)1.69%

Tangible BV CAGR (5Y)47.34%

26-Week Price Return-12.62%

Quick Ratio (Annual)4.94x

13-Week Price Return-40.13%

Total Debt / Equity (Annual)1.75x

Current Ratio (Quarterly)4.74x

Enterprise Value$297.54M

Revenue / Share Growth (5Y)10.03%

Asset Turnover (TTM)0.50x

Book Value / Share Growth (5Y)46.87%

Revenue / Employee (Annual)$214,900

Inventory Turnover (Annual)1.88x

Pretax Margin (Annual)-68.93%

Cash / Share (Annual)$1.56

3-Month Return Std Dev80.93%

Gross Margin (5Y Avg)62.85%

Net Income / Employee (TTM)$-201,000

ROE (Last FY)-91.15%

Net Interest Coverage (Annual)-9.17x

EPS Basic Excl Extra (Annual)$-0.90

Receivables Turnover (TTM)5.95x

Total Debt / Equity (Quarterly)4.66x

EPS Incl Extra (TTM)$-1.18

Receivables Turnover (Annual)6.17x

ROI (TTM)-54.94%

P/S Ratio (TTM)6.54x

Pretax Margin (5Y Avg)-77.95%

Revenue / Share (Annual)$1.31

Tangible BV / Share (Annual)$0.48

Price vs S&P 500 (52W)-79.65%

Year-to-Date Return-33.70%

5-Day Price Return-11.08%

EPS Normalized (Annual)$-0.90

ROA (5Y Avg)-35.55%

Net Profit Margin (Annual)-69.08%

Month-to-Date Return-25.72%

Cash Flow / Share (TTM)$-0.87

EBITD / Share (Annual)$-0.85

Operating Margin (Annual)-65.36%

LT Debt / Equity (Annual)1.75x

ROI (5Y Avg)-47.67%

LT Debt / Equity (Quarterly)4.66x

EPS Basic Excl Extra (TTM)$-1.18

P/TBV (Quarterly)50.33x

P/B Ratio (Annual)14.52x

Inventory Turnover (TTM)2.09x

Pretax Margin (TTM)-81.80%

Book Value / Share (Annual)$0.95

Price vs S&P 500 (13W)-42.82%

Beta1.33x

P/FCF (Annual)43.85x

Revenue / Share (TTM)$1.40

ROE (TTM)-188.09%

52-Week Low$8.27

vGradeF

gGradeB

mGradeD

vgmGradeD

CLPT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 3, 2026	-$0.29	-$0.38	-32.56%(-$0.09)
Q1 2026	May 13, 2026	-$0.27	-$0.32	-17.07%(-$0.05)
Q4 2025	Mar 17, 2026	-$0.20	-$0.27	-35.00%(-$0.07)
Q3 2025	Nov 6, 2025	-$0.20	-$0.21	-5.00%(-$0.01)
Q2 2025	Aug 12, 2025	-$0.20	-$0.21	-5.00%(-$0.01)

CLPT Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.22

4.25

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
CLPTClearPoint Neuro, Inc. Common Stock	F	B	D	6.5x	23.6%	62.6%	-73.4%	$9.07
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About ClearPoint Neuro, Inc. Common Stock

ClearPoint Neuro develops and commercializes minimally invasive surgical platforms for brain and cardiac procedures guided by real-time MRI imaging. The company's flagship ClearPoint system is currently in commercial use and addresses a significant market need for precise, image-guided neurosurgery. Revenue is generated through system sales, services, disposables, and software solutions.

CLPT Next Earnings Report

Report dateOct 28, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.32

Revenue estimate$12.30M

Also reporting on Oct 28, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for October 2026

Companies in Related Industries

FOSLFossil Group, Inc.Watches & Clocks
PREPrenetics Global Limited Class A Ordinary ShareLab Analytical Instruments
CVCapsoVision, Inc. Common StockElectromedical Equipment
SMTISanara MedTech Inc. Common StockOrthopedic & Prosthetic Devices
OPTXSyntec Optics Holdings, Inc. Class A Common StockOptical Instruments & Lenses
NAUTNautilus Biotechnolgy, Inc. Common StockLab Analytical Instruments
EYPTEyePoint, Inc. Common StockLab Analytical Instruments
QSIQuantum-Si Incorporated Class A Common StockMeasuring & Controlling Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.3

Strong Buy

Consensus rating

52-Week Range

Low$8.27

High$28.10